Clinical Trials
58 trialsA Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Incyte Corporation
Beacon-BTC
J-Pharma Co., Ltd.
CIME
Centre Leon Berard
MEND-IT II
Catharina Ziekenhuis Eindhoven
FOBEAR
Sun Yat-sen University
CAPRI-3 GOIM
University of Campania Luigi Vanvitelli
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
GlaxoSmithKline
CIRCULATEIII
UNICANCER
NALIRIFOX Plus Targeted Therapy Versus FOLFOX Plus Targeted Therapy as First-line Treatment for Metastatic Colorectal Cancer
Shanghai Zhongshan Hospital
FOXHIPECT4
Maimónides Biomedical Research Institute of Córdoba
IROCAS
UNICANCER
COMPOSE
ITM Solucin GmbH
CinClare-2
Zhejiang Cancer Hospital
FOxTROT2France
Centre Hospitalier Universitaire Dijon
PIPAC_VEROne
Azienda Ospedaliera Universitaria Integrata Verona
CAIRO5
Dutch Colorectal Cancer Group
ITACa
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Alliance for Clinical Trials in Oncology
CLAUDIA
Seoul National University Hospital
Combination of IV Ascorbic Acid and Adebrelimab in Metastatic Colorectal Cancer
Fudan University
CR-SEQUENCE
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
IDEA
GERCOR - Multidisciplinary Oncology Cooperative Group
HAIC Versus TACE for Large Hepatocellular Carcinoma Staged BCLC A/B.
Sun Yat-sen University
PROMENADE
University of Roma La Sapienza
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
Sixth Affiliated Hospital, Sun Yat-sen University
HAIC With One-day FOLFOX vs. HAIC With Two-day FOLFOX for Unresectable HCC: a Non-inferiority Study
Sun Yat-sen University
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Amgen
PelvEx II
Catharina Ziekenhuis Eindhoven
Hepatic Arterial Infusion of Raltetrexed With Oxaliplatin(SALOX) Versus FOLFOX in Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers
Sun Yat-sen University
Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer
Medical Research Council
COLOPEC
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Combination Chemotherapy With or Without Cetuximab in Treating Patients With Stage III Colon Cancer That Was Completely Removed By Surgery
Federation Francophone de Cancerologie Digestive
Sequoia
Eli Lilly and Company
GEMFOX
Assistance Publique - Hôpitaux de Paris
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
Alliance for Clinical Trials in Oncology
Adjuvant Chemotherapy in High Risk Stage II Colon Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC
Sun Yat-sen University
Triplet Combination or Doublet Regimen Versus Chemoradiation as Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Mebendazole as Adjuvant Treatment for Colon Cancer
Tanta University
Neoadjuvant HAIC for Resectable Hepatocellular Carcinoma Beyond Milan Criteria
Sun Yat-sen University
PETACC-8 miR-31-3p and miR-31-5p Ancillary Study
IntegraGen SA
HORIZON II
AstraZeneca
Adjuvant Chemotherapy With FOLFOX in HCC Patients After Resection
Sun Yat-sen University
Phase 3 Trial of Litxâ„¢ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases
Light Sciences Oncology
COMETS
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
TOSCA
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
XELOX Versus FOLFOX for Advanced Gastric Cancer (AGC)
Dong-A University Hospital